December 2014

New Product - Anoro Ellipta

Anoro Ellipta (umeclidinium (as bromide)/ vilanterol (as trifenatate)) is a combination inhaled long-acting muscarinic receptor antagonist/ long-acting beta2-adrenergic agonist (LAMA/LABA). Following inhalation both compounds act locally on airways to produce bronchodilation by separate mechanisms. Anoro Ellipta is indicated as a long-term once daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). Anoro Ellipta is contraindicated in patients with severe milk protein allergy. Anoro Ellipta (62.5 mcg/25 mcg) is available as a moulded plastic inhaler containing two aluminium foil laminate strips of 30 regularly distributed blisters.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia┬áPty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629